Trials / Conditions / High Risk Prostate Carcinoma

High Risk Prostate Carcinoma

8 registered clinical trials studyying High Risk Prostate Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk NCT06528210	OHSU Knight Cancer Institute	Phase 2
Recruiting	Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patie NCT06625970	UNICANCER	Phase 3
Recruiting	Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abira NCT06384222	Ivan de Kouchkovsky, MD	Phase 2
Recruiting	Towards Optimal Treatment for High Risk Prostate Cancer NCT06204341	Haaglanden Medical Centre	N/A
Recruiting	Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR T NCT06461793	Samsung Medical Center	Phase 2
Active Not Recruiting	[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer NCT05936658	FutureChem	Phase 3
Terminated	Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients NCT05437679	Angle plc	—
Active Not Recruiting	Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis NCT05004285	FutureChem	Phase 3